Privium Fund Management B.V. Axsome Therapeutics, Inc. Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
A detailed history of Privium Fund Management B.V. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 62,232 shares of AXSM stock, worth $7.25 Million. This represents 1.21% of its overall portfolio holdings.
Number of Shares
62,232
Previous 80,232
22.43%
Holding current value
$7.25 Million
Previous $7.21 Million
26.96%
% of portfolio
1.21%
Previous 1.8%
Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
376Shares Held
37.2MCall Options Held
1.75MPut Options Held
1.18M-
Rtw Investments, LP New York, NY4.05MShares$472 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$384 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$171 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$162 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...